Steven M Bradley
Overview
Explore the profile of Steven M Bradley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
3116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopes M, Li H, Sorensen R, Das S, Bradley S, de Lemos J, et al.
J Am Heart Assoc
. 2025 Mar;
14(5):e034186.
PMID: 40028842
Background: Limited knowledge exists about prophylactic anticoagulation patterns in patients hospitalized for COVID-19. Methods And Results: We conducted a retrospective cohort study using American Heart Association COVID-19 Cardiovascular Disease Registry...
2.
Bradley S, Das S
Circ Cardiovasc Qual Outcomes
. 2024 Nov;
17(11):e010010.
PMID: 39561237
No abstract available.
3.
Shah N, Mulder H, Lydon E, Chiswell K, Hu X, Lampron Z, et al.
J Am Heart Assoc
. 2024 Nov;
13(21):e035610.
PMID: 39494552
Background: Lipoprotein (a) is an independent risk factor for atherosclerotic cardiovascular disease. However, lipoprotein (a) testing remains variable and it is unclear what factors influence testing and if testing changes...
4.
Westenfield K, Bradley S, Stanberry L, Harris K
J Am Soc Echocardiogr
. 2024 Oct;
38(2):92-98.
PMID: 39424107
Background: Understanding ascending aortic aneurysm growth and associated risk factors is critical to advising appropriate echocardiographic follow-up intervals for patients. The aim of this study was to identify aortic aneurysm...
5.
Shah N, Mulder H, Lydon E, Chiswell K, Hu X, Lampron Z, et al.
Am Heart J
. 2024 Oct;
279:50-58.
PMID: 39423990
Background: Although guidelines recommend low-density lipoprotein cholesterol (LDL-C) to be < 70 mg/dL in patients with atherosclerotic cardiovascular disease (ASCVD), the rate of achieving this goal remains suboptimal. We sought...
6.
Jneid H, Chikwe J, Arnold S, Bonow R, Bradley S, Chen E, et al.
J Am Coll Cardiol
. 2024 Mar;
83(16):1579-1613.
PMID: 38493389
No abstract available.
7.
Jneid H, Chikwe J, Arnold S, Bonow R, Bradley S, Chen E, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Mar;
17(4):e000129.
PMID: 38484039
No abstract available.
8.
Brindis R, Bradley S
JACC Cardiovasc Interv
. 2024 Mar;
17(5):632-634.
PMID: 38479965
No abstract available.
9.
Gupta K, Mehta H, Kim H, Stebbins A, Wruck L, Munoz D, et al.
Am Heart J
. 2023 Jun;
264:31-39.
PMID: 37290700
Background: Among patients with established cardiovascular disease, the ADAPTABLE trial found no significant differences in cardiovascular events and bleeding rates between 81 mg and 325 mg of aspirin (ASA) daily....
10.
Weissler E, Stebbins A, Wruck L, Munoz D, Gupta K, Girotra S, et al.
Vasc Med
. 2023 Apr;
28(2):122-130.
PMID: 37025023
Background: We aimed to understand the effects of aspirin dose on outcomes in patients with peripheral artery disease (PAD) as well as their participation in a pragmatic randomized controlled trial....